Treatment of cutaneous T-cell lymphoma with a new aromatic retinoid (Ro 10-9359)
- 1 January 1982
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 273 (1-2) , 37-42
- https://doi.org/10.1007/bf00509025
Abstract
A 77-year-old woman developed a diffuse nodular eruption with histologic, ultrastructural, and biologic evidence of cutaneous T-cell lymphoma (CTCL) limited to the skin. She was treated with a new aromatic retinoid Ro 10-9359 (1 mg/kg/day). After 34 days, the lesions flattened completely and the mononuclear cell infiltrate decreased significantly. No clinical recurrences occured after a 4-month survey. Discontinuation of the aromatic retinoid led to a relapse with identical clinical and histologic features.This publication has 25 references indexed in Scilit:
- Oral retinoids-present statusBritish Journal of Dermatology, 1980
- Round Cells of the Epidermis: Clues from Studies on Neoplastic Lymphocytes of Cutaneous T Cell LymphomaJournal of Investigative Dermatology, 1980
- Retinoids in the treatment and prevention of dermatoses and epithelial neoplasias.1980
- Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10-9359)British Journal of Dermatology, 1980
- A Case of Centrolobular Toxic Necrosis of the Liver Due to Aromatic Retinoid – Tigason (Ro 10-9359)Dermatology, 1980
- Chemoprevention of cancer with retinoids.1979
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978
- Oral Treatment of Psoriasis and Pustulosis Palmo-plantaris with Ro 10-9359Dermatology, 1978
- The Efficacy of a New Retinoid (Ro 10-9359) in Lichen planusDermatology, 1978
- Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of micePublished by Elsevier ,1974